Johns Hopkins researchers have developed a sugar-based molecular microcapsule that eliminates the toxicity of an anticancer agent developed a decade ago at Johns Hopkins, called 3-bromopyruvate, or 3BrPA, in studies of mice with implants of human pan ...
A study by Sarah Bradbury, who graduates with a PhD in Psychology next week, shows that the development of drug addiction is related to brain levels of serotonin—a chemical created by the human body that is responsible for maintaining mood balance. ...
A research team led by Portland State University biology professor Ken Stedman has unlocked the structure of an unusual virus that lives in volcanic hot springs. The discovery could pave the way for better drugs to treat Human Immunodeficiency Virus ...
Piperaquine is a long-acting malaria drug that kills residual parasites and decreases the risk of reinfection. A study led by Uppsala University researcher Martin Bergstrand shows that increasing the dose used in children could potentially decrease t ...
The uncontrolled growth of cancer cells arises from their ability to hijack the cell’s normal growth program and checkpoints. Usually, after therapy, a second cancer-signaling pathway will open after the primary one shuts down — creating an ingenious ...
Scientists at QIMR Berghofer Medical Research Institute have used an experimental drug produced from the seeds of a rainforest plant to cure solid cancer tumors in preclinical trials. The study led by Dr. Glen Boyle at QIMR Berghofer’s Cancer Drug ...
A North Carolina drugmaker is providing its experimental antiviral drug to a Dallas patient being treated for Ebola, an emergency step authorized by the Food and Drug Administration. Officials at Texas Health Presbyterian Hospital said Monday that ...
Vivolux, a pharmaceutical company specialized in cancer treatment, announced that the FDA has granted clearance to proceed with VLX1570 Clinical Trial phase 1/2 for treatment against relapsed and/or refractory multiple myeloma. Researchers at Vivolux ...
One of the most rapidly fast-tracked vaccines in history—an anti-Ebola “ChAd3” vaccine—just entered clinical trial in humans. It may wrap in November. It protected macaques for five weeks, leaping to 10 months when followed by a booster two months la ...
The Food and Drug Administration says there is little evidence that testosterone-boosting drugs taken by millions of American men are beneficial, though the agency is also unconvinced by studies suggesting the hormone carries serious testosterone the ...